col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: IMA Press, LLC

65 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Neurology neuropsychiatry Psychosomatics 2024―Feb―26 Acute cerebrovascular accidents in patients with new coronavirus infection COVID-19 N. A. Shamalov, L. V. Klimov, M. A. Soldatov, T. V. Kiseleva, V. N. Shamalova, N. A. Marskaya, O. V. Lyang
2 [GO] Neurology neuropsychiatry Psychosomatics 2023―Dec―18 Admitting a patient with musculoskeletal pain following COVID-19 disease I. D. Romanov, O. A. Shavlovskaya, I. A. Bokova
3 [GO] Neurology neuropsychiatry Psychosomatics 2023―Dec―18 Neurohumoral gate for the entry of coronavirus into the central nervous system through the cribriform plate of the skull V. N. Nikolenko, M. V. Oganesyan, N. A. Rizaeva, A. T. Nikitina, M. P. Pavliv, А. V. Polyakova, et al. (+2)
4 [GO] Modern Rheumatology Journal 2023―Aug―21 COVID-19 and post-covid syndrome in patients with rheumatoid arthritis E. S. Aronova, B. S. Belov, G. I. Gridneva
5 [GO] Modern Rheumatology Journal 2023―Aug―21 A clinical case of development of Waterhouse-Friderichsen syndrome after SARS-CoV-2 infection in a patient with rheumatoid arthritis and secondary adrenal AA-amyloidosis O. V. Alpidovskaya
6 [GO] Modern Rheumatology Journal 2023―Jul―13 Retrospective analysis of cases of multisystem inflammatory syndrome associated with COVID-19 infection in children in the Republic of Komi N. N. Korableva, O. R. Payusova, E. V. Berestnev, O. N. Tarbeyeva, A. S. Mezentseva, T. V. Bezuglaya
7 [GO] Neurology neuropsychiatry Psychosomatics 2023―Jul―05 Inflammatory biomarkers and growth factors in patients with chronic cerebrovascular disease after coronavirus infection E. B. Kuznetsova, O. N. Voskresenskaya, N. B. Zakharova, N. S. Kuznetsov
8 [GO] Neurology neuropsychiatry Psychosomatics 2023―Jul―05 Mental disorders during the pandemic of a new coronavirus infection: clinical features V. A. Vysokova, N. A. Tyuvina, T. N. Maksimova, S. V. Prokhorova
9 [GO] Neurology neuropsychiatry Psychosomatics 2023―May―01 Clinical course and diagnosis of cerebral vein and sinus thrombosis associated with COVID-19 in young and middle-aged patients E. G. Klocheva, V. V. Goldobin, F. Z. Olimova
10 [GO] Modern Rheumatology Journal 2023―Feb―17 Axial spondyloarthritis and COVID-19: course, interactions, outcomes, and the role of vaccination Sh. F. Erdes, B. S. Belov
11 [GO] Modern Rheumatology Journal 2023―Feb―17 Clinical case of SARS-CoV-2 infection in a patient with rheumatoid arthritis and secondary AA-amyloidosis of the lungs O. V. Vorobeva, L. P. Romanova
12 [GO] Neurology neuropsychiatry Psychosomatics 2022―Dec―20 Alzheimer's disease and COVID-19 N. N. Koberskaya, F. A. Roshchin
13 [GO] Neurology neuropsychiatry Psychosomatics 2022―Dec―20 A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova
14 [GO] Neurology neuropsychiatry Psychosomatics 2022―Dec―20 Mental disorders during the pandemic of a new coronavirus infection: causes and predisposing factors N. A. Tyuvina, V. O. Vysokova, E. N. Efremova, O. V. Lavrinenko
15 [GO] Modern Rheumatology Journal 2022―Dec―19 Interleukin 6 receptor inhibitors in the treatment of rheumatoid arthritis during the COVID-19 pandemic, Moscow experience A. I. Zagrebneva, E. N. Simonova, T. V. Mezenova, N. B. Burmistrova, Yu. A. Gavrikova, Yu. A. Gavrikova, et al. (+3)
16 [GO] Modern Rheumatology Journal 2022―Dec―19 Development of bilateral episcleritis and rheumatoid arthritis after a new coronavirus infection: a description of a clinical case O. N. Matveeva, E. V. Kvasova
17 [GO] Neurology neuropsychiatry Psychosomatics 2022―Oct―25 Impact of work and study during pandemic on the mental state of medical professionals V. E. Medvedev, O. A. Dogotar, N. Yu. Lyzlova
18 [GO] Modern Rheumatology Journal 2022―Oct―20 Pathological changes in organs in rheumatoid arthritis with secondary amyloidosis of the heart and kidneys on the background of COVID-19 O. V. Vorobeva, I. P. Romanova
19 [GO] Modern Rheumatology Journal 2022―Oct―20 Shared features of pathogenetic aspects, autoimmunity and pharmacotherapy in coronavirus infection (COVID-19) and immunoinflammatory rheumatic diseases K. S. Rutskaya-Moroshan, S. T. Abisheva, A. M. Lila
20 [GO] Neurology neuropsychiatry Psychosomatics 2022―Aug―24 Cognitive impairment in patients with coronavirus infection Y. A. Starchina, O. V. Kosivtsova
21 [GO] Neurology neuropsychiatry Psychosomatics 2022―Aug―24 Clinical features of mental disorders during the pandemic of a new coronavirus infection N. A. Tyuvina, V. O. Vysokova, E. N. Efremova, O. V. Lavrinenko
22 [GO] Neurology neuropsychiatry Psychosomatics 2022―Aug―05 Review of human interferons and the potential of their use in the complex therapy of a new coronavirus infection COVID-19 E. V. Granatov, A. R. Abashev, F. A. Khabirov, A. Ya. Dykhanov, T. I. Khaibullin
23 [GO] Neurology neuropsychiatry Psychosomatics 2022―Aug―05 Autoimmune spinal cord lesions associated with novel coronavirus infection A. O. Kozlova, D. D. Eliseeva, T. O. Simaniv, V. V. Bryukhov, E. V. Baidina, M. N. Zakharova
24 [GO] Neurology neuropsychiatry Psychosomatics 2022―Jun―21 Acute and long-term neurological disorders in patients with coronavirus infection V. A. Parfenov, A. A. Kulesh
25 [GO] Modern Rheumatology Journal 2022―Jun―20 Current possibilities of pharmacological correction of neuroimmune joint damage in patients with knee osteoarthritis in long COVID conditions I. V. Sarvilina, I. S. Dydykina, A. M. Lila
26 [GO] Modern Rheumatology Journal 2022―May―08 Analysis of the mechanisms of development of neurorheumatological consequences of COVID-19 and the possibility of their pharmacological correction I. V. Sarvilina, A. M. Lila, O. A. Gromova, I. Yu. Torshin, O. A. Shavlovskaya, E. A. Taskina
27 [GO] Modern Rheumatology Journal 2022―May―08 Use of telemedicine consultations in rheumatology during the COVID-19 pandemic O. V. Teplyakova, A. A. Morozova
28 [GO] Modern Rheumatology Journal 2022―May―08 Organ changes after SARS-CoV-2 infection in a patient with systemic sclerosis according to autopsy O. V. Vorobeva, L. P. Romanova
29 [GO] Neurology neuropsychiatry Psychosomatics 2022―Feb―27 COVID-19 associated multiple cranial neuropathies M. Yu. Maksimova, Ya. O. Grusha, E. I. Fettser
30 [GO] Neurology neuropsychiatry Psychosomatics 2022―Feb―27 Validation of the Russian version of Stress and Anxiety to Viral Epidemics - 9 items (SAVE-9) among healthcare workers during COVID-19 pandemic E. S. Mosolova, S. Chung, D. N. Sosin, S. N. Mosolov
31 [GO] Modern Rheumatology Journal 2022―Feb―20 Important aspects of osteoarthritis therapy during the COVID-19 pandemic A. M. Lila, A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova
32 [GO] Modern Rheumatology Journal 2022―Feb―20 Safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (preliminary data) A. N. Kulikov, N. V. Muravyeva, B. S. Belov
33 [GO] Modern Rheumatology Journal 2022―Feb―20 COVID-19-associated angiitis: literature review and case report D. I. Abdulganieva, N. G. Shamsutdinova, A. A. Gaibaryan
34 [GO] Neurology neuropsychiatry Psychosomatics 2021―Dec―16 Causes and predictors of mental disorders during the COVID-19 pandemic N. A. Tyuvina, V. O. Vysokova, T. N. Maksimova, S. V. Prokhorova
35 [GO] Neurology neuropsychiatry Psychosomatics 2021―Dec―16 Multifactorial model of willingness to get vaccinated in medical students during 3rd wave of COVID-19 pandemic V. L. Malygin, Ya. V. Malygin, A. S. Iskandirova, E. E. Pahtusova, Yu. A. Merkuryeva, V. V. Ogarev, et al. (+2)
36 [GO] Neurology neuropsychiatry Psychosomatics 2021―Dec―16 Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova
37 [GO] Modern Rheumatology Journal 2021―Oct―20 Polyarthritis associated with COVID-19 (clinical case) E. S. Aronova, B. S. Belov
38 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Management of patients with pain syndromes associated with COVID-19 L. T. Akhmedzhanova, T. M. Ostroumova, O. A. Solokha
39 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Anticoagulant therapy for stroke prevention in patients with severe COVID-19 A. T. Azimov, G. S. Rakhimbaeva, F. Z. Azimov
40 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration I. V. Sarvilina, O. A. Gromova, A. V. Naumov
41 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Impact of mental disorders on COVID-19 outcomes N. N. Petrova, V. E. Pashkovskiy, M. S. Sivashova, A. N. Gvozdetsky, G. A. Prokopovich
42 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Obsessive-compulsive disorder during the SARS-CoV-2 pandemic (case report) N. A. Tiuvina, T. N. Maksimova, S. V. Prokhorova, V. O. Vysokova
43 [GO] Neurology neuropsychiatry Psychosomatics 2021―Sep―16 Acute inflammatory demyelinating pseudotumor after COVID-19 T. I. Yakushina, D. M. Yakushin, I. O. Shtang
44 [GO] Neurology neuropsychiatry Psychosomatics 2021―Sep―16 Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov
45 [GO] Modern Rheumatology Journal 2021―Aug―16 Septal panniculitis as manifestation of COVID-19: own data O. N. Egorova, R. G. Goloeva, D. I. Abdulganieva
46 [GO] Neurology neuropsychiatry Psychosomatics 2021―Jun―24 COVID-19 and epilepsy: Russian and international experience G. V. Odintsova
47 [GO] Neurology neuropsychiatry Psychosomatics 2021―Jun―24 Management tactics in patients with chronic cerebral ischemia during COVID-19 pandemic A. A. Kulesh
48 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) V. A. Kutashov
49 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 COVID-19 vaccination guidelines for patients with multiple sclerosis N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, et al. (+4)
50 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions V. A. Golovacheva, G. R. Tabeeva, I. V. Kuznetsov
51 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Anxiety and depression in COVID-19: treatment options V. E. Medvedev
52 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Central pontine myelinolysis in the presence of SARS-CoV-2 infection (clinical observations) O. N. Voskresenskaya, A. A. Kovalenko, E. B. Nadbitova, V. V. Grinyuk, A. V. Klimanov, Yu. M. Shor
53 [GO] Modern Rheumatology Journal 2021―Apr―24 The Prospects of tumor necrosis factor α inhibitors use in patients with COVID-19 E. S. Aronova, B. S. Belov
54 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ V. V. Kovalchuk
55 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 Anxiety: phenomenology, epidemiology, and risk factors during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic A. G. Merkin, S. S. Akinfieva, A. V. Martyushev-Poklad, O. P. Beloskurskaya, E. N. Dinov, S. L. Ostrovsky, et al. (+5)
56 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 Depression during the COVID-19 pandemic (analysis of clinical cases) I. Yu. Dorozhenok
57 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 Cognitive impairment in COVID-19 survivors T. M. Ostroumova, P. A. Chernousov, I. V. Kuznetsov
58 [GO] Neurology neuropsychiatry Psychosomatics 2020―Dec―13 COVID-19 and mental health: challenges and first conclusions V. E. Medvedev, O. A. Dogotar
59 [GO] Neurology neuropsychiatry Psychosomatics 2020―Dec―13 Somatization disorders of affective and neurotic registers during the COVID-19 pandemic (analysis of clinical cases) I. Yu. Dorozhenok
60 [GO] Neurology neuropsychiatry Psychosomatics 2020―Aug―05 Nervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis A. N. Boyko, S. A. Sivertseva, N. N. Spirin
61 [GO] Neurology neuropsychiatry Psychosomatics 2020―Jun―26 The first experience with Angiovit in the combination treatment of acute COVID-19 infection A. N. Boyko, N. A. Shamalov, O. V. Boyko, E. E. Arinina, O. V. Lyang, E. A. Dubchenko, et al. (+2)
62 [GO] Rheumatology Science and Practice 2020―Jun―24 DO NSAIDS CAUSE SPECIFIC COMPLICATIONS IN COVID-19 CORONAVIRUS INFECTION? A. E. Karateev, E. L. Nasonov, A. M. Lila
63 [GO] Rheumatology Science and Practice 2020―Jun―24 IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6 E. L. Nasonov
64 [GO] Modern Rheumatology Journal 2020―May―31 COVID-19: the new challenge for rheumatologists B. S. Belov, A. E. Karateev
65 [GO] Rheumatology Science and Practice 2020―Apr―27 CORONAVIRUS DISEASE 2019 (COVID-19): A RHEUMATOLOGIST’S THOUGHTS E. L. Nasonov
 [1] 

65 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec